| Literature DB >> 31333103 |
Ashok K Shakya1, Rajashri R Naik2, Ihab M Almasri3, Avneet Kaur4.
Abstract
The physiological effects of endogenous adenosine on various organ systems are very complex and numerous which are elicited upon activation of any of the four G-protein-coupled receptors (GPCRs) denoted as A1, A2A, A2B and A3 adenosine receptors (ARs). Several fused heterocyclic and non-xanthine derivatives are reported as a possible target for these receptors due to physiological problems and lack of selectivity of xanthine derivatives. In the present review, we have discussed the development of various new chemical entities as a target for these receptors. In addition, compounds acting on adenosine receptors can be utilized in treating diseases like inflammation, neuroinflammation, autoimmune and related diseases. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.Entities:
Keywords: A1; A2A; A2B and A3; GPCR; adenosine receptors; inflammation; irritable bowel syndrome; neuroinflammation.
Mesh:
Substances:
Year: 2019 PMID: 31333103 DOI: 10.2174/1381612825666190716145206
Source DB: PubMed Journal: Curr Pharm Des ISSN: 1381-6128 Impact factor: 3.116